GE Healthcare Completes Acquisition of Three Thermo Fisher Scientific Business Divisions
On Monday, GE Healthcare announced completion of their acquisition of Thermo Fisher Scientific’s HyClone cell culture media, sera and process liquids; Dharmacon RNAi gene modulation tools; and Sera-Mag magnetic beads businesses. In January, GE Healthcare and Thermo Fisher Scientific announced that they had entered into an agreement, which would allow GE to acquire these businesses for approximately $1.06 billion. This was a win for both businesses in that it expanded GE’s Life Sciences product portfolio and enabled Thermo Fisher’s European approval of its $13.6 billion Life Technologies acquisition